1. Home
  2. NTHI vs SMID Comparison

NTHI vs SMID Comparison

Compare NTHI & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • SMID
  • Stock Information
  • Founded
  • NTHI 2008
  • SMID 1960
  • Country
  • NTHI United States
  • SMID United States
  • Employees
  • NTHI N/A
  • SMID N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • SMID Building Materials
  • Sector
  • NTHI Health Care
  • SMID Industrials
  • Exchange
  • NTHI Nasdaq
  • SMID Nasdaq
  • Market Cap
  • NTHI 195.5M
  • SMID 206.7M
  • IPO Year
  • NTHI N/A
  • SMID 1995
  • Fundamental
  • Price
  • NTHI $6.40
  • SMID $31.47
  • Analyst Decision
  • NTHI
  • SMID
  • Analyst Count
  • NTHI 0
  • SMID 0
  • Target Price
  • NTHI N/A
  • SMID N/A
  • AVG Volume (30 Days)
  • NTHI 62.7K
  • SMID 11.2K
  • Earning Date
  • NTHI 11-14-2025
  • SMID 11-13-2025
  • Dividend Yield
  • NTHI N/A
  • SMID N/A
  • EPS Growth
  • NTHI N/A
  • SMID 81.92
  • EPS
  • NTHI N/A
  • SMID 2.22
  • Revenue
  • NTHI $59,990.00
  • SMID $88,866,000.00
  • Revenue This Year
  • NTHI N/A
  • SMID N/A
  • Revenue Next Year
  • NTHI N/A
  • SMID N/A
  • P/E Ratio
  • NTHI N/A
  • SMID $14.65
  • Revenue Growth
  • NTHI N/A
  • SMID 16.37
  • 52 Week Low
  • NTHI $3.20
  • SMID $25.13
  • 52 Week High
  • NTHI $25.00
  • SMID $51.96
  • Technical
  • Relative Strength Index (RSI)
  • NTHI 31.38
  • SMID 26.71
  • Support Level
  • NTHI $8.93
  • SMID $37.08
  • Resistance Level
  • NTHI $9.57
  • SMID $40.00
  • Average True Range (ATR)
  • NTHI 1.15
  • SMID 2.17
  • MACD
  • NTHI -0.46
  • SMID -0.68
  • Stochastic Oscillator
  • NTHI 0.00
  • SMID 11.35

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

Share on Social Networks: